Literature DB >> 11692166

Functional characterization of the human prion protein promoter in neuronal and endothelial cells.

H Funke-Kaiser1, S Theis, T Behrouzi, A Thomas, K Scheuch, F S Zollmann, M Paterka, M Paul, H D Orzechowski.   

Abstract

Human prion diseases such as Creutzfeld-Jakob disease and kuru are of major medical and biological importance because of their fatal course, epidemic potential, and unique pathophysiology. Endogenous expression of the normal cellular prion protein (PrP(C)) is necessary for infection and prion replication. However, knowledge of human PrP(C) gene regulation is rudimentary. We therefore cloned1543 bp of the 5' untranslated and promoter region of the PrP gene. Using transient transfection assays, the full-length promoter and serial deletion mutants subcloned in a luciferase reporter vector were analyzed in neuronal (KELLY) and endothelial (EA.hy926) cell lines, which both express PrP(C) as shown by RT/PCR. Analysis of promoter constructs in KELLY cells indicated two activating regions at -131/-284 and -1303/-1543, relative to the 3'-terminal end of exon 1, and also two repressing elements at -254/-567 and -567/-909 in neuronal cells. In EA.hy926 cells, activating elements were identified at -131/-284 and -284/-567, and one repressing region was localized at -567/-909. In addition, transcriptional start sites were determined by 5'-RACE reaction and RNase protection assay, revealing one major transcriptional start site located at -47 (in KELLY cells), -53 (in human thalamus) and at about -55 (in EA.hy926 cells).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692166     DOI: 10.1007/s001090100270

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  5 in total

1.  Activation and repression of prion protein expression by key regions of intron 1.

Authors:  Josephine A Wright; Patrick C McHugh; Mark Stockbridge; Samantha Lane; Silvia Kralovicova; David R Brown
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

2.  The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.

Authors:  Moustapha Cissé; Eric Duplan; Marie-Victoire Guillot-Sestier; Joaquim Rumigny; Charlotte Bauer; Gilles Pagès; Hans-Dieter Orzechowski; Barbara E Slack; Frédéric Checler; Bruno Vincent
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

3.  Two adjacent nuclear factor-binding domains activate expression from the human PRNP promoter.

Authors:  Michael J Taheny; Nerik Izkhakov; Alexander A Vostrov; Wolfgang W Quitschke
Journal:  BMC Res Notes       Date:  2009-09-09

4.  PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism.

Authors:  Matthew T Bishop; Catherine Pennington; Craig A Heath; Robert G Will; Richard S G Knight
Journal:  BMC Med Genet       Date:  2009-12-26       Impact factor: 2.103

5.  Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer.

Authors:  Marc-André Déry; Julie Jodoin; Josie Ursini-Siegel; Olga Aleynikova; Cristiano Ferrario; Saima Hassan; Mark Basik; Andréa C LeBlanc
Journal:  Breast Cancer Res       Date:  2013-03-12       Impact factor: 6.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.